This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!
Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

NIH NLM Logo
Log in
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2013 Sep 3;18(3):304-6.
doi: 10.1016/j.cmet.2013年08月01日5.

Leptin, GABA, and glucose control

Affiliations
Comment

Leptin, GABA, and glucose control

Barbara B Kahn et al. Cell Metab. .

Abstract

Leptin mimics many of the antidiabetic actions of insulin in insulin-deficient diabetes, but the mechanism is controversial. Fujikawa et al. (2013) reveal that leptin receptors in γ-aminobutyric acid (GABA)-ergic and pro-opiomelanocortin (POMC) neurons in the central nervous system are sufficient to mediate the lifesaving and antidiabetic actions of leptin in insulin-deficient mice.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Metabolic effects of insulin deficiency and CNS leptin in Type 1 diabetes A. Alterations of glucose metabolism in T1DM. Autoimmune destruction of pancreatic ß cells markedly reduces insulin secretion, which increases glucagon secretion from pancreatic α cells. Hyperglucagonemia drives HGP resulting in hyperglycemia. Insulin deficiency reduces glucose utilization in peripheral tissues such as BAT, white adipose tissue (WAT) and skeletal muscle, further contributing to hyperglycemia. Insulin also regulates peripheral metabolism via the CNS, including inhibition of HGP and lipid metabolism in WAT. Whether impairment of these central effects of insulin contributes to the metabolic abnormalities in T1DM is unknown. B. Anti-diabetic actions of leptin. Leptin is released mainly from white adipose tissue and acts through LEPR on GABAergic as well as POMC neurons, to induce anti-diabetic actions in the insulin-deficient state. Leptin inhibits the activity of AgRP/NPY/GABA neurons, while it activates that of POMC neurons in the ARC. The 2nd order neurons for leptin’s anti-diabetic actions may be located in the paraventricular hypothalamus (PVH), lateral hypothalamus (LH) VMH or brainstem. LEPR in GABAergic neurons in other hypothalamic regions such as the dorsomedial hypothalamus (DMH) may also mediate leptin’s actions on glycemia. Through its effects on GABAergic and POMC neurons, leptin suppresses HGP and increases glucose utilization in peripheral tissues such as BAT and skeletal muscle. Suppression of the hyperglucagonemia that is characteristic of insulin deficiency appears to be critical for the suppression of HGP by leptin, whereas the mechanism for the leptin-induced increase in glucose utilization is unknown.

Comment on

References

    1. Fujikawa T, Berglund ED, Patel VR, Giorgio Ramadori G, Vianna CR, Vong L, Thorel F, Chera S, Herrera PL, Lowell BB, Elmquist JK, Pierre Baldi P, Roberto Coppari R. Cell Metab. 2013 - PMC - PubMed
    1. German JP, Thaler JP, Wisse BE, Oh-I S, Sarruf DA, Matsen ME, Fischer JD, Taborsky GJ, Jr, Schwartz MW, Morton GJ. Endocrinology. 2011;152:394–404. - PMC - PubMed
    1. Hedbacker K, Birsoy K, Wysocki RW, Asilmaz E, Ahima RS, Farooqi IS, Friedman JM. Cell Metab. 2010;11:11–22. - PubMed
    1. Kong D, Tong Q, Ye C, Koda S, Fuller PM, Krashes MJ, Vong L, Ray RS, Olson DP, Lowell BB. Cell. 2012;151:645–657. - PMC - PubMed
    1. Meek TH, Matsen ME, Dorfman MD, Guyenet SJ, Damian V, Nguyen HT, Taborsky GJ, Jr, Morton GJ. [10.1210/en.2013-1328];Endocrinology. 2013 - PMC - PubMed
Full text links
Elsevier Science full text link Elsevier Science Free PMC article
Cite

AltStyle によって変換されたページ (->オリジナル) /